Trial Profile
An Exploratory Pharmacogenomics Study of Erbitux [cetuximab] Monotherapy in Patients With Metastatic Non Small Cell Lung Carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Oct 2015
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Non-small cell lung cancer
- Focus Pharmacogenomic; Therapeutic Use
- 13 Nov 2005 New trial record.